The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 226,055 | 15,808 | SH | SOLE | 15,808 | 0 | 0 | |||
| ADICET BIO INC | COM | 007002108 | 41,096 | 17,488 | SH | SOLE | 17,488 | 0 | 0 | |||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 428,308 | 1,019 | SH | SOLE | 1,019 | 0 | 0 | |||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 86,062 | 43,465 | SH | SOLE | 43,465 | 0 | 0 | |||
| KYVERNA THERAPEUTICS INC | COM | 501976104 | 393,614 | 15,846 | SH | SOLE | 15,846 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 161,796 | 10,319 | SH | SOLE | 10,319 | 0 | 0 | |||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 273,207 | 29,065 | SH | SOLE | 29,065 | 0 | 0 | |||
| MOLECULAR TEMPLATES INC | COM NEW | 608550208 | 306,580 | 136,866 | SH | SOLE | 136,866 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 3,363,366 | 1,318,967 | SH | SOLE | 1,318,967 | 0 | 0 | |||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 970,988 | 1,856 | SH | SOLE | 1,856 | 0 | 0 | |||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 11,300,499 | 5,113,348 | SH | SOLE | 5,113,348 | 0 | 0 | |||